Episode 128: Debate of the Decade: RCTs in the Era of Precision Oncology
Healthcare Unfiltered
00:00
The Importance of Trials in CML
I think the burden of proof is on, you know, the new technology. Let's just do an experiment and figure out. But I don't think we should be waving our hands and making stuff up. We need to give patients therapies that yes, they have improved survival, but not by much. And a lot of them would not choose to go with standard of care.
Play episode from 44:11
Transcript
